Drug Trial Radar · NCT02062073
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
Last checked: Nov 20, 2026Latest source record: Apr 29, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
238
Actual
Start
Jan 2014
Primary completion
Mar 2014
Study completion Jun 2014
Sponsor
- Lead sponsor
- Dr. Reddy's Laboratories Limited, IndiaIndustry
- Sponsor type
- Industry
- Collaborators
- TKL Research, Inc.; Accelovance
- First posted
- Feb 13, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Purpose of this study will be to determine the potential of abametapir lotion to induce sensitization by repeated topical application to the healthy skin of humans under controlled conditions.
Conditions
- Head Lice
Interventions
Abametapir Lotion 0.74% w/wDrug
0.1% sodium lauryl sulfateOther
saline 0.9%Other
Vehicle LotionOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- to evaluate the sensitizing potential of abametapir lotion using repeat insult patch test designTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
TKL Reserach
Paramus, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.